drugset / Trial / NCT00377936
EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas
RandomizedParallel-groupOpen-labelTreatment
Summary
The intention of this trial is to evaluate safety and efficacy of a combination treatment of EndoTAG-1 with Gemcitabine versus Gemcitabine monotherapy.
Timeline
- Start
- 2005-09
- Primary completion
- 2008-06
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gemcitabine | Small molecule | 1000 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 11 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 22 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 44 mg/m2 | — |